BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu C, Zhou X, Long Q, Zeng H, Sun Q, Chen Y, Wu D, Liu L. Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene. Oncogene. 2021;40:233-245. [PMID: 33110233 DOI: 10.1038/s41388-020-01521-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Chhetri D, Vengadassalapathy S, Venkadassalapathy S, Balachandran V, Umapathy VR, Veeraraghavan VP, Jayaraman S, Patil S, Iyaswamy A, Palaniyandi K, Gnanasampanthapandian D. Pleiotropic effects of DCLK1 in cancer and cancer stem cells. Front Mol Biosci 2022;9:965730. [DOI: 10.3389/fmolb.2022.965730] [Reference Citation Analysis]
2 Safrastyan A, Wollny D. Network analysis of hepatocellular carcinoma liquid biopsies augmented by single-cell sequencing data. Front Genet 2022;13:921195. [DOI: 10.3389/fgene.2022.921195] [Reference Citation Analysis]
3 Kashyap A, Tripathi G, Tripathi A, Rao R, Kashyap M, Bhat A, Kumar D, Rajhans A, Kumar P, Chandrashekar DS, Mahmood R, Husain A, Zayed H, Bharti AC, Kashyap MK. RNA splicing: a dual-edged sword for hepatocellular carcinoma. Med Oncol 2022;39:173. [PMID: 35972700 DOI: 10.1007/s12032-022-01726-8] [Reference Citation Analysis]
4 Liu L, Liao R, Wu Z, Du C, You Y, Que K, Duan Y, Yin K, Ye W. Hepatic stellate cell exosome-derived circWDR25 promotes the progression of hepatocellular carcinoma via the miRNA-4474-3P-ALOX-15 and EMT axes. Biosci Trends 2022. [PMID: 35934785 DOI: 10.5582/bst.2022.01281] [Reference Citation Analysis]
5 Li WJ, Wu DW, Zhou YF, Zhang CW, Liao XW. Prognostic biomarker replication factor C subunit 5 and its correlation with immune infiltrates in acute myeloid leukemia. Hematology 2022;27:555-64. [PMID: 35544695 DOI: 10.1080/16078454.2022.2072064] [Reference Citation Analysis]
6 Xu F, Chen J, Huang D. Pan-cancer analysis identifies FAM49B as an immune-related prognostic maker for hepatocellular carcinoma. J Cancer 2022;13:278-89. [PMID: 34976189 DOI: 10.7150/jca.65421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tominaga N. Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles. Cancers (Basel) 2021;13:6303. [PMID: 34944923 DOI: 10.3390/cancers13246303] [Reference Citation Analysis]
8 Chang WA, Tsai MJ, Hung JY, Wu KL, Tsai YM, Huang YC, Chang CY, Tsai PH, Hsu YL. miR-150-5p-Containing Extracellular Vesicles Are a New Immunoregulator That Favor the Progression of Lung Cancer in Hypoxic Microenvironments by Altering the Phenotype of NK Cells. Cancers (Basel) 2021;13:6252. [PMID: 34944871 DOI: 10.3390/cancers13246252] [Reference Citation Analysis]
9 Wang Y, Zhao R, Jiao X, Wu L, Wei Y, Shi F, Zhong J, Xiong L. Small Extracellular Vesicles: Functions and Potential Clinical Applications as Cancer Biomarkers. Life (Basel) 2021;11:1044. [PMID: 34685415 DOI: 10.3390/life11101044] [Reference Citation Analysis]
10 Wang K, Feng X, Zheng L, Chai Z, Yu J, You X, Li X, Cheng X. TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs. Front Mol Biosci 2021;8:690500. [PMID: 34262942 DOI: 10.3389/fmolb.2021.690500] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Li A, Zhao Y, Li Y, Jiang L, Gu Y, Liu J. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles. Drug Deliv 2021;28:1237-55. [PMID: 34142930 DOI: 10.1080/10717544.2021.1938757] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
12 Guan MC, Ouyang W, Wang MD, Liang L, Li N, Fu TT, Shen F, Lau WY, Xu QR, Huang DS, Zhu H, Yang T. Biomarkers for hepatocellular carcinoma based on body fluids and feces. World J Gastrointest Oncol 2021; 13(5): 351-365 [PMID: 34040698 DOI: 10.4251/wjgo.v13.i5.351] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
13 Guo L, Li B, Lu Z, Liang H, Yang H, Chen Y, Zhu S, Zeng M, Wei Y, Liu T, Jiang T, Xuan M, Tang H. CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis. Front Mol Biosci 2021;8:674863. [PMID: 34055889 DOI: 10.3389/fmolb.2021.674863] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Zhou X, Liu C, Zeng H, Wu D, Liu L. Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma. Biosci Rep 2021;41:BSR20202870. [PMID: 33835133 DOI: 10.1042/BSR20202870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Chakrapani HB, Chourasia S, Gupta S, Kumar D T, Doss C GP, Haldar R. Effective utilisation of influence maximization technique for the identification of significant nodes in breast cancer gene networks. Comput Biol Med 2021;133:104378. [PMID: 33971587 DOI: 10.1016/j.compbiomed.2021.104378] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Wang K, Guan C, Shang X, Ying X, Mei S, Zhu H, Xia L, Chai Z. A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer. Aging (Albany NY) 2021;13:7416-29. [PMID: 33686968 DOI: 10.18632/aging.202601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]